Literature DB >> 8144544

Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates.

N Blumenfeld1, H Gonen, A Mayer, C E Smith, N R Siegel, A L Schwartz, A Ciechanover.   

Abstract

Ubiquitin-carrier proteins (E2s, ubiquitin-conjugating enzymes, UBCs) participate in proteolysis by catalyzing transfer of activated ubiquitin to the protein substrates, which are bound to specific ubiquitin-protein ligases (E3s). Yeast UBC2 (RAD6) and the mammalian E2(14kDa) bind to the ligase that recognizes and is involved in the degradation of certain free amino-terminal substrates ("N-end rule" substrates). As such proteins are rather scarce, the role of these E2s in general proteolysis is probably limited. Here, we report the purification and characterization of a novel 18-kDa species of E2 from rabbit reticulocytes. Unlike most members of the E2 family, this enzyme does not adsorb to anion exchange resin in neutral pH, and it is purified from the unadsorbed material (Fraction 1). Thus, it is designated E2-F1. Like all members of the E2 family, it generates a thiol ester with ubiquitin that serves as an intermediate in the conjugation reaction. Sequence analysis revealed a significant homology to many known species of E2s. The enzyme generates multiply ubiquitinated proteins in the presence of an E3 that has not been characterized yet. Most importantly, the ubiquitination via this E2 leads to the degradation of certain non-"N-end rule" substrates such as glyceraldehyde-3-phosphate dehydrogenase (Val at the NH2 terminus) and to the ubiquitination and degradation of certain N-alpha-acetylated proteins such as histone H2A, actin, and alpha-crystallin. The enzyme is also involved in the conjugation and degradation of the tumor suppressor protein p53.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144544

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding.

Authors:  O Abu Hatoum; S Gross-Mesilaty; K Breitschopf; A Hoffman; H Gonen; A Ciechanover; E Bengal
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Provirus integration into a gene encoding a ubiquitin-conjugating enzyme results in a placental defect and embryonic lethality.

Authors:  K Harbers; U Müller; A Grams; E Li; R Jaenisch; T Franz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

4.  Carcinoma of the lung: warts and all.

Authors:  A F Markham
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

5.  Diverse fate of ubiquitin chain moieties: The proximal is degraded with the target, and the distal protects the proximal from removal and recycles.

Authors:  Hao Sun; Sachitanand M Mali; Sumeet K Singh; Roman Meledin; Ashraf Brik; Yong Tae Kwon; Yelena Kravtsova-Ivantsiv; Beatrice Bercovich; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-13       Impact factor: 11.205

6.  Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.

Authors:  I Stancovski; H Gonen; A Orian; A L Schwartz; A Ciechanover
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

7.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.

Authors:  I Alkalay; A Yaron; A Hatzubai; A Orian; A Ciechanover; Y Ben-Neriah
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.

Authors:  Kwang-Jin Oh; Anna Kalinina; Jing Wang; Keiko Nakayama; Keiichi I Nakayama; Srilata Bagchi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  A human ubiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's disease locus on chromosome 14q24.3.

Authors:  P A Robinson; J P Leek; J Thompson; I M Carr; A Bailey; T P Moynihan; P L Coletta; N J Lench; A F Markham
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.